Judith Campisi | |
---|---|
Born | March 12, 1948 |
Died | January 19, 2024 | (aged 75)
Nationality | American |
Alma mater | Stony Brook University |
Known for | Cellular senescence |
Awards | Longevity Prize from the Ipsen Foundation Olav Thon Foundation Prize |
Scientific career | |
Fields | Biogerontology |
Institutions | Buck Institute SENS Research Foundation Lifeboat Foundation |
Judith Campisi (March 12, 1948 – January 19, 2024) was an American biochemist and cell biologist. She was a professor of biogerontology at the Buck Institute for Research on Aging. She was also a member of the SENS Research Foundation Advisory Board and an adviser at the Lifeboat Foundation. She was co-editor in chief of the Aging Journal, together with Mikhail Blagosklonny and David Sinclair, and founder of the pharmaceutical company Unity Biotechnology. She is listed in Who's Who in Gerontology. She was widely known for her research on how senescent cells influence aging and cancer — in particular the Senescence Associated Secretory Phenotype (SASP).[1][2]